Alzheimer's disease, brain imaging studies reveal clues to its progressionCategory: Alzheimer's News
Article Date: 20 Nov 2005
A novel imaging agent heralded for its potential to diagnose Alzheimer's disease during life is now giving researchers information never before available about how and where the disease progresses in the brain. Results of this new research involving Pittsburgh Compound-B (PIB) - which binds to the telltale beta-amyloid deposits in the brain of Alzheimer's patients - were presented by University of Pittsburgh researchers today at Neuroscience 2005, the 35th Annual Meeting of the Society for Neuroscience, being held Nov. 12-16 in Washington, D.C.
A novel imaging agent heralded for its potential to diagnose Alzheimer's disease during life is now giving researchers information never before available about how and where the disease progresses in the brain. Results of this new research involving Pittsburgh Compound-B (PIB) - which binds to the telltale beta-amyloid deposits in the brain of Alzheimer's patients - were presented by University of Pittsburgh researchers today at Neuroscience 2005, the 35th Annual Meeting of the Society for Neuroscience, being held Nov. 12-16 in Washington, D.C.
posted by Valery Yermalitsky at
9:22 AM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home